Special discussion with the National Institutes of Health (NIH)’s National Center for Advancing Translational Sciences (NCATS) on 3D Bioprinting during the American Association for Cancer Research (AACR) Virtual Meeting Week 1. Moderated by Dr. Sophia Ononye-Onyia, Founder and CEO, The Sophia Consulting Firm.  Featuring Mr. Sam Michael, Chief Information Officer and Director, Automation and Compound Management at the National Center for Advancing Translational Sciences (NCATS) and Dr. Marc Ferrer, Director of NCATS’ intramural 3-D Tissue Bioprinting Laboratory. The NIH is the largest public funder of biomedical research in the world, investing about $37 billion annually in medical research and the AACR Annual Meeting highlights the latest discoveries from across the spectrum of innovative cancer science and medicine. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-nih-3d-bioprinting-aacr-2021